On November 1, 2023 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, reported that members of the RAPT management team will participate in the following investor conferences in November (Press release, RAPT Therapeutics, NOV 1, 2023, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-participate-several-upcoming-investor-3 [SID1234636653]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks: 5th Annual I&I Conference – Fireside chat on Tuesday, November 7, 2023 at 3:10 p.m. ET

UBS BioPharma Conference 2023 – Fireside chat on Wednesday, November 8, 2023 at 4:00 p.m. ET

Piper Sandler 35th Annual Healthcare Conference – Fireside chat on Tuesday, November 28, 2023 at 2:30 p.m. ET

6th Annual Evercore ISI HealthCONx Conference – Fireside chat on Wednesday, November 29, 2023 at 2:35 p.m. ET

To access the available live webcasts or subsequent archived recordings of the discussions, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.